Your browser doesn't support javascript.
loading
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group.
Kordkheili, Aria Mohammadi; Bekker, Charlotte; Hoens, Alison M; Voshaar, Marieke; Campbell, Willemina; Carmona, Loreto; de Wit, Maarten; March, Lyn; Nielsen, Sabrina Mai; Shea, Beverley J; Toupin-April, Karine; Tugwell, Peter; Tymms, Kathleen; Kelly, Ayano.
Affiliation
  • Kordkheili AM; Faculty of Medicine & Health, School of Clinical Medicine, South West Sydney Campuses, University of New South Wales, Sydney, Australia.
  • Bekker C; Radboud University Medical Center, Research Institute for Health Sciences, Department of Pharmacy, Nijmegen, the Netherlands.
  • Hoens AM; Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada; OMERACT Patient Research Partner, Canada.
  • Voshaar M; Department of Pharmacy and Department of Research & Innovation, Sint Maartenskliniek and Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Campbell W; OMERACT Patient Research Partner, Canada.
  • Carmona L; Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.
  • de Wit M; OMERACT Patient Research Partner, the Netherlands.
  • March L; Department of Rheumatology, Royal North Shore Hospital, Sydney NSW, Australia.
  • Nielsen SM; Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
  • Shea BJ; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada.
  • Toupin-April K; School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada; Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Children's Hospital of Eastern Ontario Research Institute; Institut du savoir Montfort.
  • Tugwell P; University of Ottawa, Department of Medicine, Faculty of Medicine, Ottawa, Canada; Bruyère Research Institute, Ottawa, Canada; Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Canada; University of Ottawa, School of Epidemiology and Public Health, Faculty of Medicine, Ottaw
  • Tymms K; Canberra Rheumatology, Canberra, ACT, Australia; Department of Rheumatology, Canberra Hospital, Canberra, Australia; College of Health and Medicine, Australian National University, Canberra, Australia.
  • Kelly A; Faculty of Medicine & Health, School of Clinical Medicine, South West Sydney Campuses, University of New South Wales, Sydney, Australia; Department of Rheumatology, Liverpool Hospital, Sydney, Australia; Ingham Institute of Applied Medical Research, Sydney Australia. Electronic address: ayano.ke
Semin Arthritis Rheum ; 66: 152411, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38537323
ABSTRACT

OBJECTIVES:

To identify barriers, facilitators, and strategies for future implementation of the OMERACT-Adherence Core Outcome Set (COS) in medication adherence trials for rheumatic conditions.

METHODS:

Preliminary Delphi survey findings were discussed at OMERACT 2023, utilising the Consolidated Framework for Implementation Research 2 to identify implementation barriers, facilitators, and solutions.

RESULTS:

Implementation strategies included simplifying the COS definitions, making it adaptabile for clinical practice and drug trials, adherence trial training workshops, and collaborating with key stakeholders such as payers and other COS developers.

CONCLUSION:

Ongoing collaboration with individuals and organisations within and beyond rheumatology ensures broader applicability of OMERACT-Adherence COS.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology / Rheumatic Diseases / Antirheumatic Agents / Medication Adherence Limits: Humans Language: En Journal: Semin Arthritis Rheum Year: 2024 Document type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rheumatology / Rheumatic Diseases / Antirheumatic Agents / Medication Adherence Limits: Humans Language: En Journal: Semin Arthritis Rheum Year: 2024 Document type: Article Affiliation country: Australia